Alopecia (hair loss) is a common consequence of cancer treatment known to have a profound impact on quality of life.  Tourniquet technologies have been investigated from the mid-1960s to early 1980s as a strategy for preventing chemotherapy-induced alopecia (CIA) but their ambiguous results precluded incorporation into any standard of treatment [1].  Fundamental advances inherent in [...]